ELIZABETH CLEMOW-TILLEY: Open Payments
NPI 1053372045 · STUART, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$738 in 19 payments from 7 companies in 2025. Trend: 2023 $691 · 2024 $192 · 2025 $738
Food & beverage: $649Education: $89
| Company | Payments | Amount |
|---|---|---|
| Actelion Pharmaceuticals US, Inc. | 3 | $221 |
| Insmed, Inc. | 4 | $204 |
| GlaxoSmithKline, LLC. | 7 | $194 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $47 |
| Novartis Pharmaceuticals Corporation | 1 | $28 |
| Regeneron Healthcare Solutions, Inc. | 1 | $26 |
| Philips North America LLC | 1 | $18 |
Products named: Arikayce, NUCALA, UPTRAVI, OPSUMIT, TRELEGY ELLIPTA, XOLAIR, DUPIXENT, OFEV.
Industry payments across FL — which companies pay providers there.
